Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Neptune sets price for secondary offering at $27.50 per share
Neptune set the price for a secondary offering of 9,841,395 Class A shares at $27.50 per share; the shares are being sold by selling shareholders and the company will not receive any proceeds. Neptune intends to repurchase and retire 984,140 shares from the underwriters at $26.40 per share; closing is expected on Friday and is subject to customary conditions and the successful completion of the offering. The underwriters have been granted a 30-day option to purchase up to 1,476,209 additional shares at the offering price. Morgan Stanley is lead left bookrunner; the S-1 was declared effective by the SEC on May 13, 2026. The stock is trading at $27.94, market capitalization is $3.95 billion, analysts expect a return to profitability, and InvestingPro currently views the stock as overvalued. » Más en de.investing.com
Neptune announces secondary placement of 8.36 million shares by selling shareholders
Certain selling shareholders of Neptune intend to publicly place 8,355,615 class A common shares; the syndicate banks have a 30-day option on up to 1,253,342 additional shares. Neptune will also repurchase 835,561 shares from the syndicate banks at the same price and cancel them, subject to customary closing conditions and a successful offering. Morgan Stanley is lead left bookrunner, J.P. Morgan and Goldman Sachs are active bookrunners; a Form S-1 registration statement has been filed with the SEC but is not yet effective. The announcement follows a 22% rise in the stock last week; Neptune is due to report results in two days, and analysts expect a return to profitability. » Más en de.investing.com
Neptune targets IPO in New York after strong growth and high margin
Flood insurer Neptune has filed for an IPO in New York and plans to list under the ticker NP. The company, founded in 2018, reported $119.3m in revenue and $34.6m in net income in 2024, implying roughly a 29% margin; H1 2025 also showed further strong growth. The offering is being led by Morgan Stanley, J.P. Morgan and BofA Securities, with BMO Capital Markets, Goldman Sachs and Evercore ISI as additional syndicate banks. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | 2023 | YoY |
|---|---|---|
| Ingresos | 48,4 M | 9,82 % |
| Beneficio bruto | -4,51 M | 58,63 % |
| Beneficio neto | -75,17 M | 11,21 % |
| EBITDA | -58 M | 19,61 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 762,89 mil € |
Número de acciones | 4,29 M |
Máximo/mínimo de 52 semanas | 0,18 € - 0,18 € |
| Dividendos | No |
Beta | 2,19 |
Ratio P/E | -2,77 |
Ratio PEG | -0,02 |
Ratio P/B | 4,91 |
Ratio P/S | 0,00 |
Perfil de la empresa
Neptune Wellness Solutions Inc. opera como una empresa integrada de salud y bienestar. Desarrolla una cartera de marcas de estilo de vida y productos de consumo envasados bajo las marcas Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh y NurturMe. La compañía ofrece soluciones llave en mano de desarrollo de productos y cadena de suministro a clientes empresariales en diversos sectores de salud y bienestar, como el cannabis legal y el cáñamo, los nutracéuticos y los productos de consumo envasados de marca blanca. También participa en la extracción, purificación, formulación y fabricación de productos de salud y bienestar, como productos a base de omega-3 y cáñamo en diversas formas de administración, como cápsulas blandas, líquidos, cápsulas, vaporizadores, aerosoles, tópicos, sobres, tinturas, concentrados, comestibles y bebidas, así como geles desinfectantes de manos, termómetros sin contacto y guantes. Además, la compañía ofrece Maxsimil, una tecnología de administración de ácidos grasos omega-3 que utiliza enzimas que imitan el sistema digestivo natural humano para predigerir los ácidos grasos omega-3. Tiene un acuerdo de colaboración con International Flavors & Fragrances Inc. para codesarrollar productos de CBD derivados del cáñamo para el mercado masivo de venta minorista y para los mercados de salud y bienestar. La compañía se constituyó en 1998 y tiene su sede en Laval, Canadá.
| Nombre | Neptune Wellness Solutions |
| CEO | Lisa H. Gainsborg CPA |
| Sede | Laval,
qc Canadá |
| Sitio web | |
| Sector | Materiales |
| Industria | Productos químicos |
| Salida a bolsa | 13/08/2007 |
| Empleados | 50 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | NEPT |